Sam Chun Dang Pharm
Scope
Date
~
-
Aerospace & Defense
LIG Nex1 participates in Malaysia's DSA 2024
South Korea's major defense system developer LIG Nex1 Co. announced on Tuesday that it's participating in the Defence Services Asia (DSA) 2024 exhib...
May 07, 2024 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharm set to export Envlo Tab to Russia, CIS
Daewoong Pharmaceutical, a leading South Korean pharmaceutical company will export its new diabetes drug Envlo Tab. (active ingredient:enavogliflozi...
Dec 01, 2023 (Gmt+09:00)
-
Bio & Pharma
Chong Kun Dang rallies on $1.3 bn deal with Novartis
Chong Kun Dang Pharmaceutical Corp.'s shares zoomed more than 25% on Monday on news that the South Korean medicine developer has signed its biggest-...
Nov 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Pharm gets GMP certification from Japan
Celltrion Pharm Inc. announced on Wednesday that its pre-filled syringe (PFS) production facility in Cheongju, North Chungcheong Province has obtain...
Sep 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Yungjin Pharm's new drug candidate gets Fast Track from FDA
South Korea's Yungjin Pharm has secured Fast Track designation from the US Food and Drug Administration (FDA) for its new drug candidate KL1333, des...
Sep 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharm to start global clinical trials for immune-oncology drug
South Korea's Hanmi Pharmaceutical Co. announced on Tuesday that it has received approval for the phase 1 clinical trial plan of the immune-oncology...
Aug 22, 2023 (Gmt+09:00)
-
Bio & Pharma
Dongwha Pharm to buy Vietnamese pharmacy chain at $30 mn
South Korea's Dongwha Pharm announced on Thursday that it signed an agreement to acquire a 51% stake in Trung Son Pharma, a leading pharmacy chain i...
Aug 04, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharm to develop obesity drug customized for S.Korean
South Korea's Hanmi Pharmaceutical Co. plans to develop the GLP-1 class "Epeglenatide," which it received as a technology return from Sanofi S.A., i...
Jul 31, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
Tinder owner Match Group taps Sam Ahn as Asia's chief innovation officer
Match Group Inc., operating online dating and chat platforms like Tinder, Hinge and OkCupid in some 40 languages, has appointed its subsidiary Hyper...
Jul 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Daehwa Pharm applies for approval of anti-dementia patch in China
South Korea's Daehwa Pharm Co. is speeding up its advance into the Chinese market for anti-dementia medicine, applying for sales approval of its pat...
Jun 16, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharm's Efinopegdutide gets Fast Track Designation from FDA
Merck, known as MSD outside the United States and Canada, announced on Monday that Efinopegdutide, a technology transferred from the South Korean ph...
Jun 13, 2023 (Gmt+09:00)
-
Artificial intelligence
OpenAI’s Sam Altman seeks help from Korean startups, chipmakers
Sam Altman, chief executive of Microsoft-backed OpenAI and ChatGPT creator, said on Friday that he hopes to collaborate with South Korean developers...
Jun 09, 2023 (Gmt+09:00)
-
Private equity
Affinity Equity Partners’ Korea head Sam Lee resigns
Affinity Equity Partners’ Seoul office head Sam Lee has left the global investment firm, sources familiar with the matter told The Korea Econo...
Jun 07, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's ST Pharm supplies $49 mn worth of APIs to European drug firm
ST Pharm Co., a South Korean pharmaceutical firm, announced on Thursday that it had entered into an agreement to supply oligonucleotides to an undis...
Mar 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea's ST Pharm completes new R&D hub for gene therapy
ST Pharm Co., a South Korean drug raw material-producing subsidiary of Dong-A Socio Holdings, said on Friday that it has finished building an R&...
Mar 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea United Pharm signs contract to supply medicines to Saudi Arabia
Korea United Pharm. Inc. announced on Monday that it signed a contract to supply nine types of medicines, including 11 anticancer drugs, to Saudi ph...
Feb 20, 2023 (Gmt+09:00)
-
Bio & Pharma
Brazil approves Celltrion Pharm’s syringe facility
Celltrion Pharm Inc., a South Korean biopharmaceutical company, said on Monday it received certification from Brazil’s health regulator for it...
Feb 20, 2023 (Gmt+09:00)
-
Bio & Pharma
Chong Kun Dang, Synaffix ink deal to introduce ADC technology
Chong Kun Dang Pharmaceutical Corp. said on Monday that it has signed a contract with Dutch biotechnology firm Synaffix B.V for the use of antibody-...
Feb 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Ybrain, Chong Kun Dang join forces for digital medicine distribution
South Korean electroceutical platform company Ybrain Inc. said on Tuesday it has entered into a joint promotion agreement with Chong Kun Dang Pharma...
Jan 31, 2023 (Gmt+09:00)
-
Bio & Pharma
ST Pharm exports $14.6 mn worth of drug ingredients to Europe
ST Pharm Co., a South Korean company specializing in contract development and manufacturing of drug ingredients, has signed a supply contract worth ...
Jan 20, 2023 (Gmt+09:00)
-
Bio & Pharma
JVM to sell fully automated drug inspection machines in US
Hanmi Pharmaceutical Co. said on Monday that it had signed an agreement with Euclid Medical Products, a company specializing in manufacturing drug d...
Jan 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Samjin Pharm to undertake joint ADC R&D with Novelty Nobility
SamjinPharmaceutical announced Wednesday that it has signed a joint research agreement with Novelty Nobility Inc., a company specializing in antibod...
Jan 04, 2023 (Gmt+09:00)
-
Aerospace & Defense
Korea LIG Nex1 to enjoy record earnings on missile exports
LIG Nex1 Co., a leading South Korean defense company, is expected to see record earnings this year on strong missile exports, helping its shares sur...
Nov 18, 2022 (Gmt+09:00)
-
Culture & Trends
Korea must embrace diversity to sustain K-culture: Sam Richards
When Penn State University sociology professor Sam Richards introduced Korean pop culture into his lectures three years ago, he compared its power t...
Oct 25, 2022 (Gmt+09:00)
-
Bio & Pharma
KT, Hanmi-invested therapeutics maker Digital Pharm launched
Digital Pharm, jointly invested in by KT Corp. and Hanmi Pharmaceutical Co., held an official inauguration ceremony last week, the company announced...
Jun 20, 2022 (Gmt+09:00)
-
Medicine
JW Pharm exports new antibiotic substance to US
JW Pharmaceutical Co. has become the first South Korean drug maker to develop the generic version of a next-generation antibiotic substance, the med...
Jun 10, 2021 (Gmt+09:00)
-
Antidepressants
The harder the life, the better for Korea's Whanin Pharm
"When life gets too hard, this is the pharmaceutical company stock you must buy," advises the title of Hanwha Securities' recent research note on Wh...
Jun 02, 2021 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharm subsidiary JVM to sell fully automated drug inspection machines in US
Hanmi Pharmaceutical said on Monday that it had signed an agreement with Euclid Medical Products, a company specializing in manufacturing drug dis...
1 MINUTES AGO